美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

健永生技

1.70

-0.0900-5.03%

盤後：1.700.00000.00%16:10 EDT

成交量：19.15萬

成交額：33.06萬

市值：1.29億

市盈率：-42.18

高：1.82

開：1.73

低：1.67

收：1.79

52周最高：67.00

52周最低：1.43

股本：7,602.77萬

流通股本：2,873.78萬

量比：0.66

換手率：0.67%

股息：- -

股息率：- -

每股收益(TTM):-0.0403

每股收益(LYR):-0.0422

淨資產收益率：--

總資產收益率：-5.44%

市淨率：-5.75

市盈率(LYR):-40.30

資料載入中...

總覽公司新聞資訊公告

健永生技盤中異動急速上漲7.73%報2.37美元

健永生技盤中異動早盤股價大漲5.03%報1.78美元

健永生技子公司公布MCS-8（PCP）膽固醇與LDH指標II期臨床數據，揭示前列腺癌預防潛力與代謝價值

健永生技盤中異動早盤快速下跌5.25%報3.61美元

美股異動丨羚羊控股漲92.92%，為漲幅最大的中概股

健永生技：未意識到有任何重要、未公開的價格敏感信息或企業動態來解釋近期交易活動

健永生技有限公司：與一些有意購買公司普通股的投資基金進行洽談

2025年美股規模最大的IPO及其表現盤點：Anbio Biotechnology迄今漲幅最大

老虎资讯综合

健永生技擴展區域合作，與越南製藥分銷商簽署MOU，進入MCS-2市場

健永生技有限公司與韓國領先製藥公司簽署非約束性意向書，評估植物來源Mcs藥物的引進許可

健永生技：Mcs-8仍為臨床試驗新藥候選品，尚未在任何司法管轄區獲得商業使用批准

健永生技宣佈完成MCS-8二期臨床試驗主要終點統計分析，並取得積極成果

Jyong Biotech Ltd.盤中異動股價大漲5.39%報40.25美元

Jyong Biotech Ltd.盤中異動早盤大幅下跌5.01%報36.80美元

健永生技宣佈MCS-8前列腺癌預防藥物II期臨床試驗完成超700名受試者招募

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MENS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MENS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","market":"US","secType":"STK","nameCN":"健永生技","latestPrice":1.7,"timestamp":1774036800000,"preClose":1.79,"halted":0,"volume":191532,"hourTrading":{"tag":"盘后","latestPrice":1.7,"preClose":1.7,"latestTime":"16:10 EDT","volume":627,"amount":1065.8999999999999,"timestamp":1774037405089,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05027932960893859,"floatShares":28737800,"shares":76027667,"eps":-0.0403,"marketStatus":"盤後交易","change":-0.09,"latestTime":"03-20 17:36:11 EDT","open":1.73,"high":1.815,"low":1.665,"amount":330631.0244,"amplitude":0.083799,"askPrice":1.88,"askSize":1000,"bidPrice":1.69,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.0403,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774051200000},"marketStatusCode":4,"adr":0,"listingDate":1744862400000,"exchange":"NASDAQ","adjPreClose":1.79,"preHourTrading":{"tag":"盘前","latestPrice":1.79,"preClose":1.79,"latestTime":"08:00 EDT","volume":11,"amount":19.69,"timestamp":1774008003449,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.7,"preClose":1.7,"latestTime":"16:10 EDT","volume":627,"amount":1065.8999999999999,"timestamp":1774037405089,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.659555,"impliedVol":1.7181,"impliedVolPercentile":0.3902},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MENS\",,,,,undefined,":{"symbol":"MENS","floatShares":28737800,"roa":"-5.44%","roe":"--","lyrEps":-0.042184,"volumeRatio":0.659555,"shares":76027667,"dividePrice":0,"high":1.815,"amplitude":0.083799,"preClose":1.79,"low":1.665,"week52Low":1.43,"pbRate":"-5.75","week52High":67,"institutionHeld":0,"latestPrice":1.7,"committee":-0.998002,"eps":-0.0403,"divideRate":0,"volume":191532,"delay":0,"ttmEps":-0.0403,"open":1.73,"prevYearClose":3.95,"prevWeekClose":1.98,"prevMonthClose":2.14,"prevQuarterClose":3.95,"fiveDayClose":1.98,"twentyDayClose":2.01,"sixtyDayClose":4.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MENS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-01-09","symbol":"MENS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1767934800000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MENS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MENS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MENS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MENS","date":"2026-03-19","current":-44.416873,"percent":0.962963,"low":-1671.474987,"twenty":-1273.703677,"median":-469.399065,"eighty":-78.492913,"high":-38.123637,"avg":-632.07774,"sd":543.884141,"marketCap":137651136},"quantilePoints":[{"date":"2025-06-20","current":-203.776286,"twenty":-230.665817,"median":-203.776286,"eighty":-192.159849,"marketCap":615200608},{"date":"2025-06-27","current":-224.00343,"twenty":-215.938323,"median":-202.579037,"eighty":-189.726725,"marketCap":676266355},{"date":"2025-07-03","current":-195.234603,"twenty":-221.003604,"median":-203.808474,"eighty":-195.578845,"marketCap":589413267},{"date":"2025-07-11","current":-224.00343,"twenty":-224.00343,"median":-203.776286,"eighty":-193.660924,"marketCap":676266355},{"date":"2025-07-18","current":-270.722038,"twenty":-248.100396,"median":-208.75841,"eighty":-195.234603,"marketCap":817309833},{"date":"2025-07-25","current":-289.655369,"twenty":-270.672861,"median":-224.00343,"eighty":-195.578845,"marketCap":874469558},{"date":"2025-08-01","current":-468.661403,"twenty":-288.081689,"median":-239.863168,"eighty":-197.84101,"marketCap":1414888775},{"date":"2025-08-08","current":-841.426716,"twenty":-379.453451,"median":-248.592171,"eighty":-201.860688,"marketCap":2540267255},{"date":"2025-08-15","current":-973.468255,"twenty":-555.508836,"median":-270.599094,"eighty":-203.789161,"marketCap":2938900662},{"date":"2025-08-22","current":-1061.25006,"twenty":-894.144977,"median":-285.475283,"eighty":-204.775034,"marketCap":3203913932},{"date":"2025-08-29","current":-1365.166899,"twenty":-1022.00643,"median":-288.917707,"eighty":-208.610878,"marketCap":4121438867},{"date":"2025-09-05","current":-1355.085515,"twenty":-1114.607628,"median":-347.684797,"eighty":-209.004298,"marketCap":4091003169},{"date":"2025-09-12","current":-1584.006693,"twenty":-1218.618003,"median":-441.613788,"eighty":-224.00343,"marketCap":4782116207},{"date":"2025-09-19","current":-1318.177851,"twenty":-1286.23704,"median":-523.494295,"eighty":-224.00343,"marketCap":3979578933},{"date":"2025-09-26","current":-1509.21812,"twenty":-1347.708893,"median":-786.347936,"eighty":-227.445854,"marketCap":4556329503},{"date":"2025-10-03","current":-1324.54586,"twenty":-1347.708893,"median":-940.396399,"eighty":-233.593039,"marketCap":3998803952},{"date":"2025-10-10","current":-1377.018254,"twenty":-1355.085515,"median":-1003.088768,"eighty":-246.133297,"marketCap":4157218108},{"date":"2025-10-17","current":-1489.859372,"twenty":-1369.101097,"median":-1041.824955,"eighty":-247.362734,"marketCap":4497885445},{"date":"2025-10-24","current":-1542.331766,"twenty":-1407.075256,"median":-1114.607628,"eighty":-248.592171,"marketCap":4656299601},{"date":"2025-10-31","current":-1146.49633,"twenty":-1407.075256,"median":-1138.789207,"eighty":-259.411217,"marketCap":3461272420},{"date":"2025-11-07","current":-953.163578,"twenty":-1404.508884,"median":-1114.607628,"eighty":-270.476151,"marketCap":2877600843},{"date":"2025-11-14","current":-974.050648,"twenty":-1403.763891,"median":-1074.835074,"eighty":-270.722038,"marketCap":2940658906},{"date":"2025-11-21","current":-835.482773,"twenty":-1377.018254,"median":-1042.570424,"eighty":-274.164462,"marketCap":2522322492},{"date":"2025-11-28","current":-692.839373,"twenty":-1370.684528,"median":-1023.721118,"eighty":-283.213119,"marketCap":2091682067},{"date":"2025-12-05","current":-743.528724,"twenty":-1368.302652,"median":-1011.760759,"eighty":-287.245672,"marketCap":2244713218},{"date":"2025-12-12","current":-678.575033,"twenty":-1365.754127,"median":-990.09803,"eighty":-288.081689,"marketCap":2048618024},{"date":"2025-12-19","current":-84.821879,"twenty":-1357.495212,"median":-973.759452,"eighty":-287.245672,"marketCap":256077253},{"date":"2025-12-26","current":-90.680447,"twenty":-1355.282225,"median":-962.970312,"eighty":-270.623683,"marketCap":273764270},{"date":"2026-01-02","current":-100.614541,"twenty":-1352.134866,"median":-921.074128,"eighty":-247.854509,"marketCap":303755300},{"date":"2026-01-09","current":-101.888143,"twenty":-1343.873049,"median":-841.426716,"eighty":-225.3804,"marketCap":307600304},{"date":"2026-01-16","current":-90.347797,"twenty":-1334.971925,"median":-784.679158,"eighty":-205.709406,"marketCap":266074262},{"date":"2026-01-23","current":-82.514173,"twenty":-1329.160825,"median":-777.915972,"eighty":-197.84101,"marketCap":243004240},{"date":"2026-01-30","current":-66.846925,"twenty":-1324.749636,"median":-757.793064,"eighty":-192.283954,"marketCap":196864194},{"date":"2026-02-06","current":-43.346053,"twenty":-1323.272258,"median":-744.420245,"eighty":-110.344859,"marketCap":127654126},{"date":"2026-02-13","current":-38.384758,"twenty":-1315.070263,"median":-743.019283,"eighty":-99.712528,"marketCap":113043111},{"date":"2026-02-20","current":-51.963039,"twenty":-1302.639909,"median":-725.95302,"eighty":-91.39228,"marketCap":153031151},{"date":"2026-02-27","current":-60.057784,"twenty":-1286.23704,"median":-692.839373,"eighty":-89.564435,"marketCap":176870174},{"date":"2026-03-06","current":-57.446576,"twenty":-1274.188557,"median":-672.461744,"eighty":-85.125381,"marketCap":169180167},{"date":"2026-03-13","current":-56.140972,"twenty":-1274.111229,"median":-573.585372,"eighty":-82.019955,"marketCap":165335163},{"date":"2026-03-19","current":-46.740623,"twenty":-1273.703677,"median":-469.399065,"eighty":-78.492913,"marketCap":137651136}],"updateTime":1774010728027},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MENS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2616523378","title":"健永生技盤中異動 急速上漲7.73%報2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616523378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616523378?lang=zh_tw&edition=fundamental","pubTime":"2026-03-03 22:35","pubTimestamp":1772548548,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日22时35分，健永生技股票出现波动，股价急速上涨7.73%。截至发稿，该股报2.37美元/股，成交量1.9303万股，换手率0.03%，振幅5.91%。健永生技股票所在的生物技术行业中，整体跌幅为1.03%。其相关个股中，Edesa Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Adial Pharmaceuticals, Inc、Propanc Biopharma, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为114.09%、54.17%、14.46%，振幅较大的相关个股有Edesa Biotech, Inc.、Klotho Neurosciences, Inc.、Bioatla, Inc.，振幅分别为22.80%、18.80%、15.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223549a44721fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223549a44721fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2610368469","title":"健永生技盤中異動 早盤股價大漲5.03%報1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610368469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610368469?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 22:41","pubTimestamp":1770734476,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时41分，健永生技股票出现异动，股价急速上涨5.03%。截至发稿，该股报1.78美元/股，成交量2.4729万股，换手率0.03%，振幅8.28%。健永生技股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Quince Therapeutics, Inc.、Abpro Holdings, Inc、Evommune, Inc.涨幅较大，Abpro Holdings, Inc、Phio Pharmaceuticals Corp.、Quince Therapeutics, Inc.较为活跃，换手率分别为1113.00%、690.91%、577.58%，振幅较大的相关个股有Quince Therapeutics, Inc.、Abpro Holdings, Inc、Phio Pharmaceuticals Corp.，振幅分别为58.92%、21.05%、20.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210224117a6eafeeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210224117a6eafeeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1143516915","title":"健永生技子公司公布MCS-8（PCP）膽固醇與LDH指標II期臨床數據，揭示前列腺癌預防潛力與代謝價值","url":"https://stock-news.laohu8.com/highlight/detail?id=1143516915","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143516915?lang=zh_tw&edition=fundamental","pubTime":"2026-01-30 21:31","pubTimestamp":1769779896,"startTime":"0","endTime":"0","summary":"健永生技旗下子公司最新披露了MCS-8（PCP）针对胆固醇及乳酸脱氢酶（LDH）指标的II期临床试验数据。研究结果显示，该候选药物在调节血脂代谢与酶活性方面呈现显著作用，为前列腺癌的预防策略提供了新的科学依据。\n数据分析表明，MCS-8（PCP）不仅能有效改善胆固醇水平，还对LDH指标表现出调控潜力。这两项生物标志物的协同作用，暗示其在代谢性疾病干预及肿瘤预防领域具备双重价值。尤其在前列腺癌高风险人群的早期干预方面，该研究成果或将为临床实践开辟新路径。\n此次II期临床数据的发布，进一步验证了MCS-8（PCP）在多维度健康指标中的积极影响，为其后续研发与商业化应用奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2603689224","title":"健永生技盤中異動 早盤快速下跌5.25%報3.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689224?lang=zh_tw&edition=fundamental","pubTime":"2026-01-12 23:08","pubTimestamp":1768230498,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日23时08分，健永生技股票出现波动，股价急速下跌5.25%。截至发稿，该股报3.61美元/股，成交量8.9112万股，换手率0.12%，振幅4.98%。健永生技股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Beam Therapeutics Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为576.05%、119.91%、63.93%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Forte Biosciences, Inc.、Pyxis Oncology, Inc.，振幅分别为31.29%、26.68%、26.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112230818a4bb29d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112230818a4bb29d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2595874922","title":"美股異動丨羚羊控股漲92.92%，為漲幅最大的中概股","url":"https://stock-news.laohu8.com/highlight/detail?id=2595874922","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595874922?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 09:07","pubTimestamp":1767143221,"startTime":"0","endTime":"0","summary":"中概股收盘涨幅居前的个股为：羚羊控股涨92.92%，健永生技涨51.8%，众巢医学涨35.51%，东方文化涨22.98%，Scully Royalty涨19.95%。(格隆汇)","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/31/20251231242132.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/31/20251231242132.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251231/31906628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["MENS","BK4077","AEHL","BK4086","SRL","ICG","ZCMD"],"gpt_icon":0},{"id":"1112355521","title":"健永生技：未意識到有任何重要、未公開的價格敏感信息或企業動態來解釋近期交易活動","url":"https://stock-news.laohu8.com/highlight/detail?id=1112355521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112355521?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 22:05","pubTimestamp":1766153116,"startTime":"0","endTime":"0","summary":"健永生技：未意识到有任何重要、未公开的价格敏感信息或企业动态来解释近期交易活动","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1139406308","title":"健永生技有限公司：與一些有意購買公司普通股的投資基金進行洽談","url":"https://stock-news.laohu8.com/highlight/detail?id=1139406308","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139406308?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 22:05","pubTimestamp":1766153113,"startTime":"0","endTime":"0","summary":"健永生技有限公司：与一些有意购买公司普通股的投资基金进行洽谈","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1120365595","title":"2025年美股規模最大的IPO及其表現盤點：Anbio Biotechnology迄今漲幅最大","url":"https://stock-news.laohu8.com/highlight/detail?id=1120365595","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120365595?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 11:27","pubTimestamp":1766114876,"startTime":"0","endTime":"0","summary":"此次发行正值 IPO 市场整体复苏之际。这使得 2025 年成为自 2021 年以来 IPO 表现最强劲的 12 个月周期，当年共有 401 家公司在美国证券交易所挂牌。Circle Internet Group稳定币发行商 Circle 的上市是今年规模最大的 IPO 之一。自六个月前开始在股市交易以来，Circle 的股价已上涨约 168%。Miami InternationalMiami International 于 8 月上市，募集资金 3.45 亿美元。自上市以来，Miami International 的股价累计上涨 88.5%。","market":"us","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","KRMN","CRCL","NNNN","SION","WSHP","AUGO","MAZE","ALM","MIAX"],"gpt_icon":1},{"id":"1193390170","title":"健永生技擴展區域合作，與越南製藥分銷商簽署MOU，進入MCS-2市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1193390170","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193390170?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 21:31","pubTimestamp":1764855070,"startTime":"0","endTime":"0","summary":"健永生技扩展区域合作，与越南制药分销商签署MOU，进入MCS-2市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1174979431","title":"健永生技有限公司與韓國領先製藥公司簽署非約束性意向書，評估植物來源Mcs藥物的引進許可","url":"https://stock-news.laohu8.com/highlight/detail?id=1174979431","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174979431?lang=zh_tw&edition=fundamental","pubTime":"2025-11-24 21:34","pubTimestamp":1763991278,"startTime":"0","endTime":"0","summary":"健永生技有限公司与韩国领先制药公司签署非约束性意向书，评估植物来源Mcs药物的引进许可","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"1181632438","title":"健永生技：Mcs-8仍為臨床試驗新藥候選品，尚未在任何司法管轄區獲得商業使用批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1181632438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181632438?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 21:32","pubTimestamp":1763645550,"startTime":"0","endTime":"0","summary":"健永生技：Mcs-8仍为临床试验新药候选品，尚未在任何司法管辖区获得商业使用批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"1121886024","title":"健永生技宣佈完成MCS-8二期臨床試驗主要終點統計分析，並取得積極成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1121886024","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121886024?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 21:31","pubTimestamp":1763645502,"startTime":"0","endTime":"0","summary":"健永生技宣布完成MCS-8二期临床试验主要终点的统计分析，并取得了积极成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"2584672995","title":"Jyong Biotech Ltd.盤中異動 股價大漲5.39%報40.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584672995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584672995?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 22:31","pubTimestamp":1763389868,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时31分，Jyong Biotech Ltd.股票出现波动，股价快速上涨5.39%。截至发稿，该股报40.25美元/股，成交量759股，换手率0.00%，振幅0.00%。Jyong Biotech Ltd.股票所在的生物技术行业中，整体涨幅为0.38%。Jyong Biotech Ltd.公司简介：Jyong Biotech Ltd是一家以科学为导向的台湾生物技术公司，致力于开发和商业化以泌尿系统疾病治疗为主的创新和差异化新药，最初的市场重点是美国，欧盟和亚洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223108a6ff9f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223108a6ff9f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JYB","MENS","BK4139"],"gpt_icon":0},{"id":"2582537515","title":"Jyong Biotech Ltd.盤中異動 早盤大幅下跌5.01%報36.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582537515?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 00:29","pubTimestamp":1762878574,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时29分，Jyong Biotech Ltd.股票出现异动，股价快速下跌5.01%。截至发稿，该股报36.80美元/股，成交量21.4786万股，换手率0.28%，振幅5.89%。Jyong Biotech Ltd.股票所在的生物技术行业中，整体涨幅为1.26%。Jyong Biotech Ltd.公司简介：Jyong Biotech Ltd是一家以科学为导向的台湾生物技术公司，致力于开发和商业化以泌尿系统疾病治疗为主的创新和差异化新药，最初的市场重点是美国，欧盟和亚洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112002934a6f26860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112002934a6f26860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JYB","MENS","BK4139"],"gpt_icon":0},{"id":"1126531796","title":"健永生技宣佈MCS-8前列腺癌預防藥物II期臨床試驗完成超700名受試者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1126531796","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126531796?lang=zh_tw&edition=fundamental","pubTime":"2025-09-16 20:19","pubTimestamp":1758025157,"startTime":"0","endTime":"0","summary":"健永生技宣布MCS-8前列腺癌预防药物II期临床试验完成超700名受试者招募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}